Profile: Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

33.90SEK
11:29am EDT
Price Change (% chg)

-0.30kr (-0.88%)
Prev Close
34.20kr
Open
34.50kr
Day's High
34.50kr
Day's Low
33.60kr
Volume
102,145
Avg. Vol
117,273
52-wk High
81.50kr
52-wk Low
27.50kr

Search Stocks
Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As of December 31, 2011, Active Biotech had five projects in clinical phase, three of which were outlicensed. Three of the projects relate to drugs for the treatment of the autoimmune diseases, multiple sclerosis (MS), Crohn’s disease, Systemic Sclerosis and rheumatoid arthritis (RA), and two of the projects focus on drugs for the treatment of cancer, mainly renal cell cancer and prostate cancer. As of December 31, 2011, the Company had three subsidiaries, including Active Forskaren 1 KB, Actinova AB and Active Security Trading AB.

Company Address

Active Biotech AB

Scheelevagen 22
LUND     223 63
P: +4646.192000
F: +4646.191100

Search Stocks